Clinical Study

Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema

Figure 2

Mean central macular thickness (CMT) at baseline and each follow-up. Mean CMT was significantly decreased at 6 months posttreatment compared to baseline (Wilcoxon signed rank test, ).